|
|
||||||||
1 Department of Nutritional Sciences, The University of Arizona, Tucson, Arizona 85721-0038; 2 Medical Department, Xitron Technologies, San Diego, California 92121; and 3 Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona 85016
| |
ABSTRACT |
|---|
|
|
|---|
The
maintenance of body cell mass (BCM) is critical for survival in human
immunodeficiency virus (HIV) infection. Accuracy of
bioimpedance for measuring change (
) in intracellular water (ICW),
which defines BCM, is uncertain. To evaluate bioimpedance-estimated
BCM, the ICW of 21 weight-losing HIV patients was measured before and after anabolic steroid therapy by dilution (total body water by
deuterium
extracellular water by bromide) and bioimpedance. Multiple-frequency modeling- and dilution-determined
ICW did not
differ. The
ICW was predicted poorly by 50-kHz parallel reactance, 50-kHz impedance, and 200
5-kHz impedance. The
ICW predicted by 500
5-kHz impedance was closer to, but statistically
different from, dilution-determined
ICW. However, the effect of
random error on the measurement of systematic error in the 500
5-kHz method was 12-13% of the average measured
ICW; this was
nearly twice the percent difference between obtained and threshold
statistics. Although the 500
5-kHz method cannot be fully
rejected, these results support the conclusion that only the
multiple-frequency modeling approach accurately monitors
BCM in HIV infection.
human immunodeficiency virus; acquired immunodeficiency syndrome; weight loss; extracellular water; intracellular water
| |
INTRODUCTION |
|---|
|
|
|---|
A MEASUREMENT of the central, energy-exchanging mass of working tissue has long been sought as a standard for assessing nutritional status (40). The core reference for the central tissues of the body has, in the past, been identified as fat-free mass (FFM). However, the FFM is too broad, including extracellular water (ECW) and the structural bone matrix, which are largely involved with support and not direct oxidative energy turnover. On the other hand, body cell mass (BCM) consists of cellular components minus ECW and support tissue. The ability to measure BCM would provide a reference basis for the measurement of oxygen consumption, caloric requirements, basal metabolic rate, and work performance (51). From an ideal point of view, the intracellular water (ICW) most closely approximates the BCM (40, 51). This is because acute changes in body protein occur mainly in the cellular compartment (23), and changes in body protein are generally accompanied by changes in ICW (2).
The depletion of BCM and involuntary weight loss are common in human immunodeficiency virus (HIV) infection and are closely associated with morbidity and mortality (1, 26, 42). In fact, BCM loss has been observed to precede overt weight loss even in the early stages of HIV infection (42), and a critical level of BCM must be maintained for survival (26). Therefore, the ability to accurately monitor changes in BCM is essential to the successful treatment of individuals with HIV infection and acquired immunodeficiency syndrome. BCM can be estimated from total body potassium (TBK) measured with whole body counting, from ICW measured by dilution methods, or from total body nitrogen measured by neutron activation (16). However, whole body counting and neutron activation are expensive, and dilution methods are tedious and time consuming.
Theoretically, bioimpedance measurements can be used to estimate BCM noninvasively by measuring ICW; however, there is considerable debate concerning the best bioimpedance method to use. One group of investigators believes that ECW, ICW, and total body water (TBW) are best predicted using a bioimpedance spectroscopy (BIS) approach (11, 58). Others continue to advocate the approach first proposed by Thomasset in 1963 (53; see also Refs. 14, 19). Although various frequency combinations have since been used, Thomasset proposed the use of a fixed, single low-frequency (1-kHz) bioimpedance approach to measure ECW and a fixed, single high-frequency (100-kHz) bioimpedance approach to measure TBW. The ICW was computed as TBW minus ECW. A third group of investigators proposes that BCM can be adequately measured by a fixed, single-frequency 50-kHz measurement of impedance (Z) (43) or reactance (X) transformed into parallel X (XP) (7, 25, 31). Whereas the latter two approaches rely on the derivation of prediction equations for TBW, ECW, and ICW using statistical methods, BIS provides a more direct measure of body water components. In fact, BIS is the technique from which all underlying theories of the bioimpedance method evolved and implies fitting measured spectral data to a biophysical model (44).
Basic theoretical and analytic bioimpedance principles.
Biological cell membranes behave as capacitors
(Cm), and Z is frequency dependent (9) (Fig.
1). With direct current or at the zero
frequency, there is theoretically no conduction through biological
cells, and Z is purely resistive (R) and a function of ECW [R at
0 frequency (R0) or RE]. With alternating
current, Cm charges and discharges the current at
the rate of the frequency; therefore, as frequency increases, the
amount of ICW measured increases. At some infinitely (
) high
frequency (>10,000 kHz or 10 MHz; Fig. 1), the charge and discharge
of current through the cells become so fast that the effects of
Cm become insignificant, Z becomes purely resistive
(R
), and both ECW and ICW are fully measured. Once
R0 or RE and R
are determined,
ICW resistance (RI) can be computed as 1/RI = 1/R
1/R0 (Fig. 2). At
R0 and R
, the overall Z is independent of
Cm; whereas, at the middle or characteristic
frequency (fc), the dependence on the value of
Cm is at a maximum (Fig. 2). The
fc can also be defined as the frequency of maximum
X (9). The fc is an important term because it is
computed from RE, RI, and
Cm and thus changes with changes in ECW, ICW, or the
cell membranes, respectively (30). The equation for
fc is
1/[2
Cm(RE + RI)].
|
|
Comparison of BIS and single-frequency approaches. Some studies comparing the BIS and single-frequency approaches report no advantage of BIS in predicting ECW, TBW, and ICW (43). These conclusions, however, are based on the prediction of absolute volume using correlation, standard error of estimate (SEE), and bias statistics. It is well known that ECW, ICW, and TBW are highly intercorrelated and that Z measured at any frequency can equally predict the absolute volume of each body water compartment (11, 43, 58). This intercorrelation would be expected because ECW and ICW are generally tightly regulated and comprise TBW. Detection of any systematic error (Esys) that would impair the measurement of change in fluid compartments by a particular bioimpedance method would be obscured by the high intercorrelation of the variables when only absolute volume is predicted. For this reason, the ability to measure change should be the test of the validity of a bioimpedance method. Furthermore, correlation and SEE statistics should not be used to assess change, because neither of these statistics is sensitive to scaling; thus the predicted change could be significantly different from the actual change. For example, the correlation and SEE for the set of numbers 10, 15, 20, and 25 compared with the set 5, 7.5, 10, and 12.5 would be a perfect 1 and 0, respectively, despite the 50% difference between the sets.
Although it has been reported that the Kotler et al. (25) XP equation detected direction of change in 89% of the subjects with a BCM change (
BCM)
5%, the accuracy of the
prediction of the actual
BCM was not reported. A method that
predicts direction of change (i.e., positive or negative) but is in
error by 50% would have little clinical value. To assess change,
multiple measurements must be made, and this greatly increases the
effect of random error. At the same time, that which is being measured
(change) is significantly less than absolute volume, often by a factor of 10 (e.g., 2 vs. 20 liters). To accurately measure ICW change (
ICW) in an individual, a method must have small Esys
and random errors. How well a method measures what it purports to
measure is the major uncontrollable contributor to Esys.
Thus the closer the theory underlying a method matches reality, the
smaller the Esys and the better the measurement of change.
Van Loan et al. (55) recently reported that, after gonadal hormone
replacement therapy in HIV-positive men, the BIS method accurately
predicted change in FFM (
FFM) compared with the estimated accretion
of lean tissue from nitrogen balance measured daily for 21 days with
the use of 24-h urine and fecal collections. It was also reported that
the BIS method predicted
FFM better than did dual-energy X-ray
absorptiometry or deuterium (2H) dilution. Because the
cellular compartment would have retained most of the increased nitrogen
(23), the results of this study strongly suggest that the BIS method is
sensitive to
BCM. Given that BCM is most closely related to ICW, the
aim of the present study was to determine which bioimpedance method
would provide the most accurate estimate of
ICW compared with
ICW
measured by dilution (difference between 2H dilution for
TBW and bromide dilution for ECW). It was hypothesized that BIS would
provide valid measures of ICW (BCM) and would estimate
ICW with
better accuracy than would other bioimpedance methods. To accomplish
this aim, measures of ICW by bioimpedance were compared with criterion
dilution measures of ICW in patients with HIV infection receiving
anabolic steroid therapy for treatment of weight loss.
| |
SUBJECTS AND METHODS |
|---|
|
|
|---|
Study design.
This study was part of a larger clinical evaluation of HIV-infected
individuals who were undergoing treatment for weight loss with the
anabolic steroid oxandrolone (Oxandrin, BTG Pharmaceuticals, Iselin,
NJ). Oxandrolone is an orally administered testosterone derivative
(2-oxa analog of 17
-methyldihydrotestosterone) that was approved by
the FDA more than 30 years ago "as adjunctive therapy to promote
weight gain after weight loss following extensive surgery, chronic
infections, or severe trauma, and in some patients who without definite
pathophysiologic reasons fail to gain or to maintain normal weight"
(3). Dose-dependent anabolic effects of oxandrolone in normal healthy
subjects were demonstrated by decreased nitrogen excretion and
increased protein synthesis with an anabolic potency 6.3 times that of
methyltestosterone (17). Oxandrolone has been used successfully to
treat growth failure (Turner's syndrome) in children (48) and has been
safely used to treat protein-energy malnutrition in alcoholic liver
disease (4, 5, 35, 36). Oxandrolone has also been shown to
significantly increase body weight (Wt) and muscle function after burn
injury (12).
Subjects. Subjects were recruited from an outpatient clinic with a population of ~600 HIV-infected patients. Any individual with a history of weight loss, who was receiving standard antiretroviral therapy and whose primary care physician prescribed Oxandrin therapy, was recruited to participate in the study. Twenty-one subjects (20 men, 1 woman) between the ages of 27 and 56 yr, with a mean age of 41 ± 7.7 yr, completed this study. Of these, 20 subjects (19 men, 1 woman) were maintained on an Oxandrin dose of 20 mg/day, whereas one subject's dose was reduced to 10 mg/day after 1 mo. At the time of baseline assessment, the subjects had experienced an average weight loss of 9%. Ethnic distribution of the subject population was 72% (15 subjects) Caucasian, 14% (3 subjects) Hispanic, and 14% (3 subjects) African-American. The study protocol was approved by the Human Subjects Committee of The University of Arizona, and written, informed consent was obtained from all participants.
Procedures. Subjects came to the Metabolic Monitoring Laboratory at The University of Arizona for comprehensive assessment of body composition before initiation and after termination of Oxandrin therapy. To standardize testing conditions and to avoid acute changes in hydration status, subjects were instructed to abstain from vigorous exercise for at least 12 h and to abstain from alcohol and caffeine consumption for 48 h before assessment. Subjects reported to the laboratory on test days in the morning, after an 8- to 12-h fast.
Anthropometric assessment. At each visit, Wt was measured to the nearest 0.1 kg with a digital platform scale [Kubota model K-10-300L-A, Chugai Boyeki (America), Commack, NY]. Subjects were instructed to wear the same lightweight clothing at each visit. Standing height (Ht) was measured to the nearest 0.5 cm with a stadiometer (Narragansett Machine, Providence, RI).
Dilution volume.
Criterion estimates of TBW and ECW were derived from 2H and
bromide dilution, respectively. While still in a fasted state and after
baseline urine and venous blood samples were collected, subjects were
given a weighed dose of deuterium oxide (2H2O;
99.8 atom percent; Isotec, Miamisburg, OH) equivalent to 0.15 g/kg TBW.
To calculate the dose, an estimate of TBW was obtained by
single-frequency bioimpedance analysis by using the Kushner et al. (29)
equation. Immediately afterward, the subjects drank a measured dose of
a sodium bromide (NaBr; Sigma Chemical, St. Louis, MO) solution,
providing 1.0 ml of 3% (wt/vol) solution/kg body wt. Dose solutions
were administered from paper cups and were followed by a 30-ml wash
with deionized, distilled water. A 3-h equilibration period, during
which subjects did not ingest anything, was allowed for ECW
determination by bromide dilution. A second blood sample was drawn at 3 h postbromide dosing, and a light snack was provided immediately after
the second blood draw. At 5 and 6 h after dosing with
2H2O, urine samples were collected for TBW
determination by 2H dilution. Blood samples were collected
in 10-ml tiger-top vacutainer tubes and centrifuged at 3,000 rpm for 20 min to separate serum. Two 2.5-ml aliquots of each serum sample and
three 5-ml aliquots of each urine sample were stored frozen at
80°C in airtight cryogenic vials until analysis.

standard measured 840.1 ± 1.9 (SD) 
and the
73 
standard measured
72.9 ± 1.4 
. Appropriate dilutions of the doses
were also used as internal controls. Stock dose solution was prepared
twice during the study; dose 1 was measured as 759.8 ± 1.1 (SD) 
(n = 20) and dose 2A was 733.5 ± 1.4 
(n = 21). The TBW was calculated by using a
two-point method as described by Schoeller et al. (47) using the
2H enrichment of the urine sample collected 5 h postdose
that had, in all cases, greater 2H enrichment than did the
sample collected at 6 h.
Frozen serum samples were shipped overnight to the Pennington
Biomedical Research Center, Baton Rouge, LA, for bromide analysis. Serum bromide enrichment was determined by the HPLC method of Miller
and Cappon (38) by using an HPLC (model 1090M; Hewlett Packard, Palo
Alto, CA) equipped with autosampler and diode-array detector. The
analytic precision of the bromide measurements by this technique is
~2% (38). The coefficient of variation (CV) for the bromide assay in
this study was ~5%. The ECW was calculated by using a correction of
10% for nonextracellular distribution and 5% for Donnan equilibration
(39). The ICW was estimated as the difference between TBW and ECW. The
accuracy of a dilution-determined ICW volume is unknown because ECW is
impossible to measure directly. Nonetheless, the bromide dilution
method for ECW is estimated to have an accuracy of 5% (54). Although
in animal studies there is found to be some variability in the
2H dilution method for TBW, it is reported to be accurate
within 1.5% (22). Most laboratories do not report accuracy, but rather mean intra-assay CV, which is an indication of repeatability (43). For
estimating the propagation of ICW error, we assumed the 2H
and bromide dilution methods to have accuracies of 1.5 and 5%, respectively.
The pre-Oxandrin therapy dilution-determined fluid compartments were as
follows: TBW, 39.9 liters; ECW, 17.4 liters; and ICW, 22.5 liters
(Table 1). A 1.5% error for 2H
dilution-measured TBW is 0.60 liter, and a 5% error for bromide dilution-measured ECW is 0.87 liter. Squaring and adding these two
terms (0.602 + 0.872) equals 1.12. The square
root of 1.12 is 1.06. Because volume change is being assessed, 1.06 was
multiplied by 1.414 (square root of 2) and is 1.50 liters. This is a
6.7% error in 22.5 liters of ICW, assuming that the errors in the
dilution methods are not correlated.
|
Bioimpedance measurements. After the measurement of Wt and Ht and ingestion of the 2H2O and NaBr doses, fasting subjects assumed a supine position for 30 min. The effects of orthostatic fluid shifts on Z can be considerable (i.e., 3% on recumbence, an additional 2% after 10 min, and an additional 4% after 4 h) (28). Thus the duration of recumbency before bioimpedance measurements are performed will affect the prediction of absolute volume, but, for estimation of fluid volume changes, the important thing is that repeated measurements be performed at identical time points during the recumbent period. This error was minimized by taking all measurements at the same 30-min mark after recumbence. With the use of the standard wrist-to-ankle measurement protocol (27), a Z measurement was made with a multiple-frequency bioimpedance device (model 4000B or 4200; Xitron Technologies, San Diego, CA). The multiple-frequency devices were confirmed to be in calibration according to manufacturer instructions. Three patients had baseline measurements taken with the 4000B device. All subsequent measurements were performed with the newer 4200 device. Comparison of R and X measurements by the two devices for seven subjects and 35 data points (frequencies 5, 50, 100, 200, and 500 kHz) showed no significant differences. Data were transmitted directly from the analyzer to a personal computer and controlled by the software programs supplied with the devices. All measurements were taken on the right side of the body by using disposable electrodes (IS4000; Xitron Technologies).
To evaluate the BIS method, Z and phase (
) spectral data were fit to
the Cole model (9) by using nonlinear least squares curve-fitting
software supplied with the devices. The Cole model consists of RE, RI, Cm, and
exponent
. Because it is not possible to measure Z at sufficiently
low or high frequencies, the ends of the semicircle that is formed when
R and X are plotted are extrapolated to R0 and
R
by using mathematical curve-fitting techniques (Fig.
2). Then, as discussed, RI is computed. In practice, RE, RI, Cm,
, and time
delay (Td) are simultaneously computed. The term
Cm is related to the thickness of the cell membrane
(9). Exponent
is a Cole model term that represents the suppression of the semicircle below the R axis (Fig. 2) (9). The suppressed semicircle is thought to be a result of a distribution effect caused by
the different sizes and shapes of cells (49). The term
Td is used to account for any error introduced by a
frequency-invariant time delay and allows for an improved fit to the
Cole model. The Td is caused by the interaction
between contact R, stray capacitance, and transmission line effects. A
detailed review of Td and the method by which Z
data are fit to the Cole model has been published by De Lorenzo et al.
(11). The ECW and ICW volumes were predicted by using the values of
Cole model terms RE and RI in equations developed by Xitron Technologies from mixture theory (11, 34). The TBW
was calculated as ECW plus ICW. The resistivity constants used to
predict ECW and ICW were developed by De Lorenzo et al. These constants
(scalars) were selected because they previously predicted the expected
sized ECW and TBW spaces [i.e., a TBW-to-Wt ratio of 0.60 and an
ECW-to-TBW ratio (ECW/TBW) of 0.40 for healthy young men] (11).
It is important to note, however, that differences in dilution methods
makes calibrating the scaling of the Z method (zero bias) extremely
difficult (11, 32, 57, 59). Fortunately, any bias between methods has
less of an effect on volume change because it is smaller than absolute
volume by a factor of 10.
The Z-to-body water volume relationship is not 1:1; therefore,
reliability tests should be applied to both Z measurements and
predicted water volume. Chumlea et al. (8) described reliability analyses using estimates of interobserver mean absolute difference (MAD) and technical error (TE). The MAD was computed as the difference between the mean of Z measurements taken at two time points by one
observer and the mean of corresponding measurements by a second observer. The TE provides an estimate of the magnitude of the error for
individual measurements and was computed as the square root of the sum
of d2/2N, where d is the difference between paired
measurements for an individual and N is the number of
individuals. Because the same-day interobserver MAD and TE have been
reported to be only 1% for R up to 1 MHz and X up to 100 kHz
for the Xitron 4000B device (8), no further analyses of precision were
performed. For the BIS method, no differences (P > 0.05;
paired t-test) were found for repeat measurements taken on 10 healthy subjects (with no change in electrodes) or on a simulated
electronic circuit (34). The CV for the BIS method was 1.3% for ECW
and 1.9% for TBW after repeat measurements (with repositioned
electrodes) taken using the Xitron 4000B device on 29 patients with
edema and 11 patients with gastrointestinal cancer (20). Because the
present study used a new multifrequency bioimpedance device (Xitron
4200), additional measurements were taken to assess the MAD, TE, and CV. A total of 90 measurements was obtained by taking two consecutive measurements each day over 5 consecutive days (4 consecutive days for 3 subjects) plus the day following a weekend on eight subjects (6 men, 2 women; ages 26-50 yr) for the computation of MAD. To compute TE,
the day 1 and day 2 measurements were paired for each subject. The CV for ECW, ICW, and Cm was calculated
by using the first measurement for each subject on each day (45 measurements). To simulate field conditions, the subjects performed the
measurements on each other after instructions were given on the first
day. Measurements were taken at the same time each day to minimize biological variation. Subjects were asked to wear similar clothing each
day and were instructed to refrain from eating large meals for several
hours before the test and to void immediately beforehand. Ht was
measured on the first day, and Wt was measured daily. Bioimpedance measurements were obtained as described above at the 4- to 6-min mark
after the recumbence. The raw data were fit to the Cole model, and ECW
and ICW volumes were computed.
The interday, interobserver TE with the use of the Xitron 4200 device,
with electrode repositioning, was 0.072 liter for ECW and 0.110 liter
for ICW. The average MAD for daily consecutive measurements was 0.022 liter for ECW and 0.066 liter for ICW. The mean MAD for the entire
period was 0.56 liter (0.28
1.02 liter) for ECW and 1.08 liter
(0.76
1.50 liter) for ICW. Relative to the dilution-determined
ECW and ICW volumes obtained in this study (Table 1), this represents
2.8 and 3.8% maximum variation (including normal biological variation)
in the ECW and ICW, respectively. The interday, interobserver CVs for
ECW and ICW measurements with electrode repositioning were 1.28%
(0.013 liter) and 1.72% (0.017 liter), respectively.
To evaluate the validity of the single low-frequency method for
predicting ECW volume, the following 5-kHz equations were used: the
Deurenberg et al. (14) Z [ECW5 Z (D)],
Hannan et al. (20) R [ECW5 R (H)], and
Segal et al. (50) R [ECW5 R (S)]. The ECW
was also estimated by subtracting the predicted ICW from the predicted
TBW by using the Kotler et al. (25) 50-kHz XP [ICW50 X (K)] and Z
[TBW50 Z (K)] equations, respectively. To evaluate the single high-frequency method for predicting TBW, the
following equations were used: TBW50 Z (K) (25),
Deurenberg et al. (14) 100-kHz R
[TBW100 R (D)], Segal et al. (50) 100-kHz R [TBW100 R (S)], Hannan et al. (20)
200-kHz R [TBW200 R (H)], and Hannan et
al. (19) 500-kHz R [TBW500 R (H)]. For
the three subjects whose baseline measurements were made using the
4000B device, R measured at 204 and 488 kHz was used to compute TBW. Because the average differences for seven subjects between R measured at 200 and 204 kHz and between R measured at 488 and 500 kHz were only
0.3 ± 0.5 and 0.8 ± 0.7%, respectively, no further analyses were performed.
To evaluate the single-frequency method for predicting ICW, the ECW
predicted by the 5-kHz equations was subtracted from the TBW predicted
by the 100-, 200-, and 500-kHz equations. Two published 50-kHz
equations developed specifically from subjects with HIV infection were
also evaluated (25, 43). For the ICW50 X (K) method,
X was transformed as suggested into XP and used in
published male and female exponential equations to predict TBK (25). To obtain ICW volume, predicted TBK was divided by 150 mmol. This is valid
because potassium is primarily distributed in ICW, and the relation
between TBK and BCM is through the TBK-to-ICW relationship (40). The
Paton et al. (43) 50-kHz Z equation
[ICW50 Z (P)] was also used. For 17 subjects and 38 measurements, no difference was observed between R and
X (
= 0.05; P = 0.063 and P = 0.139, respectively)
measured at 50 kHz by the Xitron 4000B or 4200 devices and the RJL
model 101A device (RJL Systems, Clinton Township, MI).
Data analysis.
To evaluate the fit to the Cole model, the total weighted least squared
error was computed by the modeling routine. The fit error is expressed
as a ratio between conformance to model to accuracy specification of
the device. A ratio of 1 would indicate that conformance to model was
equal to device performance. The expected accuracy at each measured
frequency is established as a pair of arrays (Z and
). The error
ratio is then established at each modeling point by dividing the
modeling error by the corresponding stored array error. Additional
statistical analyses were carried out by using SPSS version 8.0 software (SPSS, Chicago, IL). For descriptive statistics, means and SDs
were computed. Repeated-measures ANOVA was used to compare pre- and
post-Oxandrin therapy Wt and dilution-determined TBW, ECW, and ICW volumes.
and then adding and
subtracting this term from Eavg chg
(Eavg chg ± RMSE/
). The
Esys likely falls within the range of values produced.
Two-tailed paired t-tests were used to determine whether
estimated average
ECW,
TBW, and
ICW for each method compared
with the dilution method were statistically different. Because the
changes in fluid volumes in some subjects were found to be similar in
magnitude (100%) to the random measurement error, a 90% confidence
level (
= 0.10) was used to determine statistical significance. This reduced the probability of making a type II error and increased the
power of the experiment (41). An
of 0.05 was used for comparing
instruments because the uncertainty was expected to be far less (1%).
The null hypothesis was that the test mean was not different from the
criterion (dilution) mean.
Bland-Altman plots were not constructed because determining both the
random error and Esys is a more in-depth analytic approach rather than a simple visual analysis. However, to evaluate how well
each method predicted
ICW at the individual level, the difference between predicted
ICW by the various Z methods and the dilution method was computed for each subject, and the results were categorized as
1.0, 1.5, 2.0, 2.5, or 3.0 and >3.5 liters. The total percent represented by each category and the cumulative percent were computed. This presentation of the data is useful because the prediction accuracy
of the individual data points can be categorized.
| |
RESULTS |
|---|
|
|
|---|
Study findings of fluid compartment change after Oxandrin therapy
indicate that both TBW and ICW increased considerably (P < 0.0005; repeated-measures ANOVA), whereas ECW did not change (Table 1).
Consequently, ECW/TBW decreased. The data fit the Cole model with high
precision as evidenced by the low total least squares fit error ratio
(Table 2). The fit error ratio for the pre-Oxandrin therapy data does not include the three subjects measured
at baseline with the Xitron 4000B device. The routine that was used to
model the 4000B data does not display a fit error ratio. However, the
fit was rated as good, which means that the fit error ratio equaled 1, and the correlation of fit for these three subjects was >0.997.
Consistent with theory, RE was greater than R at 5 kHz and
continued to decrease with increasing frequency. Interestingly,
Cm increased as would likely occur with an increase in intracellular hydration (44). The data used for evaluating the
various bioimpedance equations are shown in Table 2.
|
Prediction of absolute body water volume.
As reported previously, the prediction of absolute ECW, TBW, and ICW
volume was similar for all methods tested. Because all 5-kHz ECW
equations provided similar predictions, only the
ECW5 R (H) equation (20) is reported. Similarly, the
two 100-kHz TBW equations evaluated (14, 50) resulted in predictions
similar to those obtained using 50 and 200 kHz. Thus only the
predictions from the TBW50 Z (K) (25),
TBW200 R (H) (20), and
TBW500 R (H) (19) equations are reported. The
single-frequency equations used for the predictions being reported are
shown in Table 3. Correlation and SEE for
ECW estimates by all methods ranged from 0.78 to 0.92 and 1.04 to 1.70 liter, respectively (Table 4). Subtraction
of the ICW50 X (K)-predicted ICW from the
TBW50 Z (K)-predicted TBW produced the best
correlation and SEE for ECW (Table 4). For the prediction of absolute
TBW volume, correlation and SEE for all methods ranged from 0.90 to
0.97 and 1.15 to 2.09 liter, respectively (Table 4). The
TBW50 Z (K) equation predicted TBW with the highest
correlation and lowest SEE.
|
|
Prediction of body water volume change.
The correlation of
ECW was similar for the BIS and
ECW5 R (H) methods and slightly higher for the
TBW50 Z (K)
ICW50 X (K) approach (Table 5). The bromide-determined
ECW was small, and all methods detected this. The
ECW predicted
by BIS was different (P = 0.022) from that estimated by the
dilution method. All methods exhibited Esys, because zero
(a perfect answer) was not a possible outcome. For every method, the
error was of positive polarity (Table 5; Fig.
3).
|
|
TBW was similar for all methods, ranging from
0.73 to 0.82 (Table 5). However, for the TBW50 Z (K)
and TBW200 R (H) approaches, the predicted
TBW was
different (P = 0.008 and P = 0.003, respectively) from
that determined by the dilution method. In addition, the random error
(RMSE) was almost as large as the
TBW predicted by these methods
(Table 5). There was no difference between the
TBW predicted by BIS
and TBW500 R (H) (P = 0.109 and P = 0.429, respectively). The RMSE and the predicted average change were
better for the TBW500 R (H) approach compared with
the BIS method (Table 5). Additionally, TBW500 R (H)
had less Esys than did the other methods, because only for
this method was zero (a perfect result) a possible outcome (Table 5;
Fig. 3).
The correlation of
ICW was similar for all methods, ranging from
0.59 to 0.68 (Table 5). The RMSE was also similar among methods. Only
the
ICW predicted by BIS did not differ (P = 0.570) from the
dilution method (Table 5). In addition to being statistically different
from criterion, ICW predicted by ICW50 X (K),
ICW50 Z (P), and TBW200R (H)
ECW5 R (H) had a random error (RMSE) that was larger
than the predicted
ICW. The BIS method had far less Esys than did all other methods. The Eavg chg was
small (0.22 liter), and only for the BIS method was zero a possible
outcome (Table 5; Fig. 3). The predicted average
TBW by
TBW500 R (H) had an error of
0.24 liter, and
the predicted average
ECW by ECW5 R (H) had an
error of +0.30 liter. Because ICW is computed by the high- and
low-frequency method as TBW minus ECW, the error in the predicted average
ICW is determined by subtracting the ECW error from the TBW
error. It is important to note that this resulted in virtually twice
the error (
0.54 liter) in the predicted average
ICW by TBW500 R (H)
ECW5 R (H)
(Table 5). As shown in Table 6, for all but
the BIS and TBW500 R (H)
ECW5 R (H) methods, approximately one-third or more
of the predictions had an error as large as the mean
criterion
ICW of 2.4 liters (Table 5). The
ICW50 X (K), ICW50 Z (P), and
TBW200 R (H)
ECW5 R (H)
methods predicted
ICW very poorly. Although the
TBW500 R (H)
ECW5 R (H)
method performed slightly better than the other single-frequency
methods, 33% of the predictions of
ICW were only within 2.0 liters
of criterion. The TBW500 R (H)
ECW5 R (H) method either predicted
ICW very well
or only moderately. Such a disproportionate distribution of results
suggests the emergence of error under certain conditions. On the other
hand, the distribution of the BIS results suggests that this method is
primarily affected only by random error.
|
| |
DISCUSSION |
|---|
|
|
|---|
R would be expected to change when ECW and ICW change, but it was of interest that Cm increased. In vitro studies have shown Cm to be inversely related to cell membrane thickness (9); therefore, an increase in Cm suggests swelling of the cells and thinning of the membranes (44). Such a finding appears consistent with the theory of Häussinger et al. (21) that an increase in cellular hydration acts as an anabolic proliferative signal. However, not only are there many factors that can affect Cm, but it can change when there is no change in ICW. For example, Cm increased 45% from pre- to posthemodialysis with virtually no change in ICW (32). De Lorenzo et al. (11) discussed the difficulties of using Cm to estimate ICW (BCM). Furthermore, its use appears unnecessary because ICW can be determined. Although repeat measurements of Cm on healthy adults and a simulated circuit showed no significant differences (34), the accuracy of determining Cm is dependent on the accuracy of the model fit. Evaluation of the accuracy of fit to the Cole model has been fully discussed by De Lorenzo et al. For repeated measures, the CV for Cm in this study was 5%.
Because it is difficult to relate fc, defined as
the frequency of maximum X, to a Z plot, it is useful to conceptualize
fc as defined by Schwan (49). He defined
fc as the frequency corresponding to Z at the
midpoint between Z at frequencies zero and infinity (Fig. 1). At any
frequency other than zero and infinity, the proportion of ICW volume
measured varies with fc, and fc
varies when ECW, ICW, or Cm change (30, 32). Thus
predictions of ECW using anything other than R0 should be
less sensitive to
ECW, because a portion of ICW will be included in
the measurement. Theory (9), mathematical simulation, and initial in
vivo results suggest that this is so (32). In this study, the BIS
prediction of ECW was statistically different from the criterion.
However, the random error effect on the measurement of Esys
was 0.17 liter or 43% of the measured average change of 0.40 liter
(Table 5). Furthermore, the random error (RMSE) in each measure of
change was, for all bioimpedance methods, larger (0.72-0.82 liter)
than the average dilution
ECW. Therefore,
ECW was too small to
draw any conclusions from the findings of this study (Table 5). It is
important to consider that an Eavg chg of 0.4 liter (Table 5; Fig. 3) represents only 2% of a total ECW volume of
17.5 liters (Table 1). The BIS method has been used successfully to
predict
ECW in comparison with bromide dilution (15), with net fluid
balance during surgery (52), and with volume removed by ultrafiltration
during dialysis (60). However, it needs to be clearly established
whether it performs better than the fixed low-frequency (e.g., 5-kHz)
approach. Gudivaka et al. (18) reported that only an equation using
Cole model term RE accurately predicted
ECW. All
predictions were corrected by 1.6% based on the assumption that change
in plasma albumin affects the total ECW volume. Coincidentally, 1.6%
was effectively the same as the magnitude of the under- and
overprediction of
ECW using the Xitron ECW equation. Because the ECW
equation published by Xitron (34) corrects for mixture effects, the
additional 1.6% correction applied by Gudivaka et al. was, in effect,
a double correction.
The TBW500 R (H) method predicted
TBW well;
however, these results need to be qualified. The fc
values for the subjects in this study ranged from 30 to 66 kHz and are
similar to the 40-60 kHz measured for healthy subjects (11). The
range of fc values obtained makes the difference
between Z at 500 kHz and infinity small (Table 2; Fig. 1). Had the
fc values been higher, less ICW would have been
measured, and the sensitivity of 500 kHz to
TBW would have been
reduced. This is supported by the finding that the 50- and 200-kHz
methods did not accurately predict
TBW. It has long been known that
fc changes considerably when tissue hydration
changes (30). For example, fc values >200 kHz
have been reported in hemodialysis patients (11), and
fc values >500 kHz have been reported in young
children with severe diarrheal disease (37). Although it is unsound to
fit a theory to a result, the ratio of the measurement frequency to
fc may be useful for exploring the cause for the
results of this study. For a measurement frequency of 200 kHz and an
fc of 50 kHz, the ratio is 4 (200/50). This
suggests that, to achieve the same results when fc
is 125 kHz, a measurement frequency of 500 kHz would be required.
Following this reasoning, if fc is 300 kHz, a
measurement frequency of 1.2 MHz would be required to produce the same
poor prediction of
TBW that 200 kHz yielded in this study. The fact
that the 500-kHz equation (19) accurately predicted
TBW may be due
in part to the similarity of fc values for the
subjects of this study (Table 2) to the 40- to 60-kHz values determined
for healthy subjects (11). This suggests that a measurement
frequency-to-fc ratio of 10 (500/50) may be needed
to accurately predict
TBW by using a single-frequency measurement.
If this were so, a measurement frequency of 2 MHz would be needed if
fc were 200 kHz. However, using a very high single
frequency to reduce the error introduced by fc
would still be problematic, because a twofold increase in frequency
increases measurement error by a factor of 4. Thus a measurement at 1 MHz is four times less accurate than a measurement at 500 kHz. This
partially explains why multiple-regression analyses provide the best
TBW predictions at frequencies between 200 and 500 kHz and why accuracy
decreases progressively at frequencies >500 kHz (13). Although the
BIS method correctly predicted
TBW in this study, it did have
Esys (Table 5; Fig. 3). Because TBW is predicted as ECW
plus ICW, the Esys in the predicted TBW may have simply
been carried over from ECW and ICW. The P value for BIS-predicted TBW was only 9% above the threshold for considering the
results different, whereas the effect of random error on the measurement of Esys was 0.373 liter or 13% of the measured
average change of 2.8 liters (Table 5). Although the TBW predicted by BIS was not different from the criterion (P = 0.109), further research is needed to confirm these findings. An Eavg
chg of 0.65 liter is only a 1.6% error in 40 liters of TBW
(Table 1).
Although it has recently been reported that a multiple-regression
equation including XP accurately predicted
ICW in
healthy, nonobese subjects (18), we found that the
ICW50 X (K) and ICW50 Z (P) methods
predicted
ICW poorly. This discrepancy may be at least partly
explained by the fact that Gudivaka et al. (18) used an
of 0.05 to
test for differences between methods, which can increase the risk of a
type II error in a situation in which sample sizes and the changes
measured are small. An evaluation of how well a method performed is not
possible without the actual P values for each method.
Furthermore, from a physics standpoint, at any single frequency, the
effect of a change in ECW, ICW, or Cm on X cannot be
discerned; therefore, any prediction of ICW using XP would
be circumstantial (32). The
ICW predicted by the fixed high- and
low-frequency methods [TBW200 R (H)
ECW5 R (H) and TBW500 R (H)
ECW5 R (H)] was also considered statistically
different from the criterion. A poor single-frequency prediction of TBW or ECW would result in a poor prediction in ICW because it is computed
as TBW minus ECW by these methods. In addition, a change in
fc causes errors in the predicted ECW and TBW in
opposite directions, thereby magnifying ICW error (Table 5). When
fc increases, a fixed low frequency (5 kHz) becomes
closer to zero, and a fixed high frequency (500 kHz) becomes further
from infinity. The opposite would occur when fc
decreases (Fig. 2). In this study, the changes in
fc were very small, but fc can
change by as much as 50% (11). Such a large change in
fc would cause large errors in the predicted
ICW. Although the
ICW predicted by TBW500 R (H)
ECW5 R (H) was different (P = 0.093)
from that determined by criterion methods, it is important to consider
these results carefully. The probability (P = 0.093) that the
results achieved were true was only slightly (7%) below the
significance level for considering the results equal. On the other
hand, the effect of random error on the measurement of Esys
was 0.30 liter or 12-13% of the measured average change of 2.4 liters (Table 5). As the P value becomes smaller and the null
hypothesis becomes more unreasonable, however, the point at which
results are accepted or rejected is subjective. As such, the findings
of this study do not lead to a firm rejection of the
TBW500 R (H)
ECW5 R (H) method.
Albeit the strong prediction of TBW using 500 kHz suggests otherwise,
the prediction of
TBW using a single high-frequency measurement
should be poor because the RE and RI differ by
a factor of 3 (44). To predict TBW volume, it must be assumed that TBW resistivity is constant. Such an assumption seems tenuous considering that a simple change in the ECW/ICW can alter TBW resistivity.
These results support the BIS or modeling approach. The implication is
that the BIS method predicted
BCM better than the other methods did
solely because it is based on the Cole model. To explore if this were
true, multiple-regression analysis was used to predict ICW pre-Oxandrin
therapy by using variables Ht, Wt, and RI. According to the
common single-frequency model used, Ht2/R, not R alone,
should correlate to water volume; thus multiple regression was also
performed by using variables Ht2/RI and Wt. Wt
alone can be predictive of
ICW, but it is often an additive term in
published multiple-regression equations (25) and was therefore
included. The resulting equations were used to predict ICW pre- and
post-Oxandrin therapy. The
ICW was computed, and two-tailed paired
t-tests were performed (
= 0.10). The equation using
Ht2/RI and Wt performed best. The predicted ICW
volume was similar to that obtained from the other methods (Table 4)
with pre- and post-Oxandrin correlations of 0.77 and 0.88 and SEEs of
2.27 and 1.99, respectively, but the prediction of
ICW was poor
(P = 0.015). We did not log transform RI before
running the regression analysis as suggested by Kotler et al. (25). It
was not clear from the literature how to replicate the procedure, and
it did not appear valid because XP predicted
BCM poorly
(Table 5). The implication of these findings is that a mathematical
modeling approach that solves for R0 and R
and accounts for any mixture effects should be used (11, 33).
The underlying basis for the mixture theory equations developed by
Xitron (33) is that the relationship between Z and body water should be
explained scientifically rather than randomly by using
multiple-regression analysis. Use of a physical model (the Cole model)
is an important first step, but, according to theory, the Z-to-body
water association is complex and nonlinear because of conductor (ECW
and ICW) and nonconductor (fat and bone) interactions. As such, Cole
model terms RE and RI are model terms and not
simply ECW and ICW R values, respectively. To accurately predict ECW
and ICW volume, mixture effects must be taken into account. The results
of this study seem to support this premise, because the prediction of
BCM solely by the Cole model was poor. The mixture theory equations
used in this study have been fully described (11). Gudivaka et al. (18)
recently reported that the ICW mixture equation published by Xitron
(34) predicted
ICW poorly, and that only a multiple-regression
equation, including Cole model term RI, accurately
predicted
ICW. The equation tested was the original equation
developed by Xitron, which assumes a linear relationship between
ECW/ICW and TBW resistivity, whereas the present equation in the Xitron
software, developed in 1993, assumes a nonlinear relationship. De
Lorenzo et al. (11) discussed the differences between equations.
It is generally understood that FFM is not an ideal measure of BCM
because it includes ECW and solids (40). Van Loan et al. (55) recently
reported the successful prediction of
FFM using bioimpedance. The
FFM determined by BIS accurately reflected the nitrogen balance
change in wasted acquired immunodeficiency syndrome patients after
gonadal hormone therapy (55). The first successful prediction of ECW,
TBW, and FFM with the use of BIS methods was reported in 1992 (34). The
BIS FFM equation developed by Xitron is
(D'ECW VECW) + (D'ICW VICW), where
VECW and VICW are ECW and ICW volumes, and
D'ECW and
D'ICW are the apparent
densities of the ECW and ICW and their associated materials,
respectively. The
D'ECW (1.45 g/cm3
for men, 1.48 g/cm3 for women), and
D'ICW (1.31 g/cm3
for men, 1.23 g/cm3 for women) terms were adjusted by
obtaining the best fit using FFM, predicted from dilution volumes,
against the densitometrically determined FFM (56). The traditional
single-frequency 50-kHz R-predicted TBW estimate of FFM (TBW/0.73)
assumes that the ECW-to-ICW, protein-to-ICW, and water-to-bone
relationships are fixed (59). The Xitron FFM method is theoretically
less affected by changes in ECW/ICW and would better account for
changes in body protein, assuming protein/ICW remained fixed. However,
it is still dependent on assuming a fixed water-to-bone relationship.
The above D'ECW and
D'ICW coefficients are weighted
so that the extracellular compartment influences the prediction more
than the intracellular compartment does. This is probably because the
early multifrequency devices made by Xitron predicted ECW better than
ICW. With the use of the above constants, if ECW and bone do not
change, the Xitron FFM method would reasonably predict
BCM. However,
FFM will never be a valid measure of BCM, because a change in bone or
water changes the assumed water-to-bone relationship and causes error.
On the other hand, the BIS ICW-to-BCM relationship is only dependent on
ICW/protein.
The BIS methodology used in this study has been successfully validated
in other clinical populations (15, 22, 57), and there is evidence that
ECW and ICW differences can be detected between patient groups (24,
57). Whereas these previous findings add strength to the findings of
this study, it is unknown whether the results of this study are
applicable to other populations. Hannan et al. (19) reported that the
BIS method did not accurately predict ECW and TBW, but the potential
cause was not discussed. Hannan et al. (personal communication) have
observed fc values approaching 1 MHz, and this is
consistent with the recent report of Meyer et al. (37). With an
fc of 1 MHz, which is equal to the highest
frequency measured, an accurate determination of R
would
be extremely difficult because there would be data on only one side of
the semicircle to fit (Fig. 2). Even with these constraints, however,
it appears that ECW can still be predicted accurately (15).
When fc becomes very high, it is doubtful that
either BIS or a fixed, single high-frequency measurement will
accurately predict
ICW. If an accurate bioimpedance measurement were
possible over a range of frequencies up to 5 MHz, accurate computation
of the Cole model might be possible when fc is very
high. Without consistent use of good protocol, the bioimpedance
technique can also be adversely affected by inaccurate electrode
placement, geometry differences, orthostatic fluid shifts,
inappropriate limb abduction, changes in ion concentration, changes in
core and skin temperature, and changes in vascular perfusion. Whereas
many of the above factors can be controlled, there may be instances
when they cannot. Clinicians should have a thorough understanding of
the sources and magnitude of potential error in the Z method. A
detailed description of the error sources in the Z method can be found
in the papers by Kushner et al. (28) and Scharfetter et al. (45). Each
clinical population presents unique limitations for the method. For
example, when body water is not evenly distributed in the body
segments, as in ascites, the wrist-ankle approach used in this study
would not yield valid results (46). Furthermore, when changes in body water occur faster than equilibration can occur in the body segments, as would be the case with infusion and ultrafiltration, a segmental approach must be used (52, 60).
In conclusion, the results of this study indicate that the
ICW50 X (K), ICW50 Z (P), and
TBW200 R (H)
ECW5 R (H)
methods predict
ICW poorly. The
ICW predicted by
TBW500 R (H)
ECW5 R (H) was
different from the criterion. However, the effect of random error on
the measurement of Esys was 12-13% of the average
measured
ICW with the use of this method. This was two times larger
than the difference between the obtained and critical threshold
statistics. Although the TBW500 R (H)
ECW5 R (H) method predicted
ICW with only marginal
accuracy, it can be neither clearly rejected nor accepted by the
results of this study. However, because of potential variations in
fc and the considerable Esys inherent
in this method, the utility of the TBW500 R (H)
ECW5 R (H) method is questionable. Esys indicates a poor underlying basis that will not be
corrected by simply regressing equations against larger data sets (6, 25). Random error decreases with sample size, but Esys does not. The BIS mixture theory approach convincingly provided the best
prediction of
ICW (
BCM). This was particularly evident when
individual results were compared. It can be concluded that the BIS
measurement is useful as a field method for monitoring
BCM in
HIV-infected populations.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank the patients, physicians, and staff at El Rio Special Immunology Associates, Tucson, AZ, for assistance with this research. The authors thank Paul O. Withers for ideas on data analysis, and Dr. Jennifer Rood for input on bromide analyses.
| |
FOOTNOTES |
|---|
This study was supported by an American Dietetic Association Foundation Dietitians in Nutrition Support Dietetic Practice Group Research Award, a Kraft Foods Fellowship, a Helen S. Mitchell Nutrition Scholarship, a Kappa Omicron Phi-Hettie Margaret Anthony Fellowship, and a BTG Pharmaceuticals (Iselin, NJ) gift grant.
Address for other correspondence: W. H. Howell, Department of Nutritional Sciences, The University of Arizona, P.O. Box 210038, Tucson, AZ 85721-0038 (E-mail: whhowell{at}ag.arizona.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: C. P. Earthman, Dept. of Human Nutrition, Foods and Exercise, Virginia Tech., Blacksburg, VA 24061-0430.
Received 25 May 1999; accepted in final form 9 November 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Babameto, G.,
and
D. P. Kotler.
Malnutrition in HIV infection.
Gastroenterol. Clin. North Am.
26:
393-415,
1997[ISI][Medline].
2.
Beddoe, A. H.,
S. J. Streat,
and
G. L. Hill.
Hydration of fat-free body in protein-depleted patients.
Am. J. Physiol. Endocrinol. Metab.
249:
E227-E233,
1985
3.
Berger, J. R.,
L. Pall,
C. D. Hall,
D. M. Simpson,
P. S. Berry,
and
R. Dudley.
Oxandrolone in AIDS-wasting myopathy.
AIDS
10:
1657-1662,
1996[ISI][Medline].
4.
Bonkovsky, H. L.,
D. A. Fiellin,
G. S. Smith,
D. P. Slaker,
D. Simon,
and
J. T. Galambos.
A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function.
Am. J. Gastroenterol.
86:
1200-1208,
1991[ISI][Medline].
5.
Bonkovsky, H. L.,
R. H. Singh,
I. H. Jafri,
D. A. Fiellin,
G. S. Smith,
D. Simon,
G. A. Cotsonis,
and
D. P. Slaker.
A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short-term effects on nitrogen metabolism, metabolic balance, and nutrition.
Am. J. Gastroenterol.
86:
1209-1218,
1991[ISI][Medline].
6.
Chertow, G. M.,
J. M. Lazarus,
N. L. Lew,
L. Ma,
and
E. G. Lowrie.
Development of a population-specific regression equation to estimate total body water in hemodialysis patients.
Kidney Int.
51:
1578-1582,
1997[ISI]